Form
Powder
Appearance
Whitecrystalpowder
Source
TolypoclADIuminflatum
WaterContent(KarlFisher)
≤3.0%
MeltingPoint
148-151°C
Assay
≥95.0%(asis)
HeavyMetals
≤0.02%
Impurities
Total:≤5.0%
CyclosporinDisahydroxylatedmetaboliteofcyclosporinA(CsA).CyclosporinDandothercyclosporinmetaboliteshavebeenfoundtohavelower(<10%)immunosuppressantactivitythancyclosporinA(CsA). CyclosporinDhasbeenfoundtoreversedaunorubicinresistanceinsomeresistantleukemiacellsbypossIBLyinhibitingtheeffluxfunctionsofP-glycoprotein.
Formorecyclosporinproducts,clickhere.
63775-96-2
C63H113N11O12
1216.63g/mol
CyclosporinD(andothercyclosporinA(CsA)metabolites)havelowerimmunosuppressantactivitybutmostlikelyoperateunderthesamemechanismascyclosporinA(CsA)describedbelow.
-20°C
2933.79.8500
Powder
Whitecrystalpowder
TolypoclADIuminflatum
≤3.0%
148-151°C
≥95.0%(asis)
≤0.02%
Total:≤5.0%
TOKU-E公司1981年成立于日本东京,由来自全球的顶尖专业人士组成,拥有世界领先的体外抗生素生产技术,并快速成长为世界领先的超纯抗生素供应者,以低廉的价格提供最全面的超纯抗生素,其纯度大于99%,用于动物细胞培养、植物组织培养、微生物、抗真菌及诊断等科研领域,允许研究者提高抗生素浓度,并消除污染,降低对细胞的伤害,从而提高筛选效率;该公司还提供精细化学试剂,如超纯丙烯酰胺、无尘SDS、胍盐等,极大提高了实验的精确性和安全性,可满足生命科学研究领域各科研机构,标准化组织机构的高标准需求。